Abstract
ObjectiveTo systematically review the effectiveness of hypertonic dextrose prolotherapy (DPT) on pain intensity and physical functioning in patients with lateral elbow tendinosis (LET) compared with other active non-surgical treatments. Data SourcesSystematic search of Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Web of Science, PubMed, Dimensions, Global Health, NHS Health Technology Assessment, Allied and Complementary Medicine, and OVID nursing database from inception to June 15, 2021, without language restrictions. Study SelectionTwo reviewers independently identified parallel or crossover randomized controlled trials that evaluated the effectiveness of DPT in LET. The search identified 245 records; data from 8 studies (354 patients) were included. Data ExtractionTwo reviewers independently extracted data and assessed included studies. The Cochrane Risk of Bias 2 tool was used to evaluate risk of bias. The Grading of Recommendation Assessment, Development, and Evaluation approach was used to assess quality of the evidence. Data SynthesisPooled results favored the use of DPT in reducing tennis elbow pain intensity compared with active controls at 12 weeks postenrollment, with a standardized mean difference of −0.44 (95% confidence interval, −0.88 to −0.01, P=.04) and of moderate heterogeneity (I2=49%). Pooled results also favored the use of DPT on physical functioning compared with active controls at 12 weeks, with Disabilities of the Arm, Shoulder and Hand scores achieving a mean difference of −15.04 (95% confidence interval, −20.25 to −9.82, P<.001) and of low heterogeneity (I2=0.0%). No major related adverse events have been reported. ConclusionsDPT is superior to active controls at 12 weeks for decreasing pain intensity and functioning by margins that meet criteria for clinical relevance in the treatment of LET. Although existing studies are too small to assess rare adverse events, for patients with LET, especially those refractory to first-line treatments, DPT can be considered a nonsurgical treatment option in carefully selected patients. Further high-quality trials with comparison with other injection therapies are needed.
Highlights
Among the 3 that were not included in the quantitative synthesis, 1 study had no available data for extraction at 12-16 weeks,[52] and 2 studies had complex intervention components in addition toDPT.[48,50]
This study showed that dextrose prolotherapy (DPT) is superior to other active controls in reducing elbow pain, with a small to medium effect size and moderate heterogeneity at 12 weeks postenrollment, with evidence from low- to moderate-quality studies
Our systematic review and meta-analysis found that DPT outperformed active controls for improving pain intensity and function and met criteria for clinical relevance in the treatment of lateral elbow tendinosis (LET)
Summary
We followed the statement on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for RCTs.[28]. The protocol has been registered in the PROSPERO registry (CRD42021265178). This review included parallel or crossover RCTs that evaluated the efficacy or effectiveness of DPT in LET regardless of blinding.[29]. For crossover RCTs, only data before the crossover period were used.[30]. Potential studies were identified by searching electronic databases, including Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Web of Science, PubMed, Dimensions, Global Health, NHS Health Technology Assessment, Allied and Complementary Medicine, and OVID nursing database. A systematic search of all databases was conducted from their inception to June
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
